| Overflow Metabolism in Escherichia coli during Steady-State Growth: Transcriptional Regulation and Effect of the Redox Ratio GN Vemuri, E Altman, DP Sangurdekar, AB Khodursky, MA Eiteman Applied and environmental microbiology 72 (5), 3653-3661, 2006 | 421 | 2006 |
| Transcriptional and Physiological Responses of Bradyrhizobium japonicum to Desiccation-Induced Stress EJ Cytryn, DP Sangurdekar, JG Streeter, WL Franck, W Chang, G Stacey, ... Journal of bacteriology 189 (19), 6751-6762, 2007 | 220 | 2007 |
| A classification based framework for quantitative description of large-scale microarray data DP Sangurdekar, F Srienc, AB Khodursky Genome biology 7, 1-17, 2006 | 94 | 2006 |
| Neurofilament light levels are associated with long-term outcomes in multiple sclerosis J Kuhle, T Plavina, C Barro, G Disanto, D Sangurdekar, CM Singh, ... Multiple Sclerosis Journal 26 (13), 1691-1699, 2020 | 91 | 2020 |
| The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug trimethoprim DP Sangurdekar, Z Zhang, AB Khodursky BMC genomics 12, 1-14, 2011 | 68 | 2011 |
| Effect of soybean coumestrol on Bradyrhizobium japonicum nodulation ability, biofilm formation, and transcriptional profile HI Lee, JH Lee, KH Park, D Sangurdekar, WS Chang Applied and environmental microbiology 78 (8), 2896-2903, 2012 | 62 | 2012 |
| Thymineless death is associated with loss of essential genetic information from the replication origin DP Sangurdekar, BL Hamann, D Smirnov, F Srienc, PC Hanawalt, ... Molecular microbiology 75 (6), 1455-1467, 2010 | 54 | 2010 |
| Blood protein markers of neocortical amyloid-β burden: a candidate study using SOMAscan technology N Voyle, D Baker, SC Burnham, A Covin, Z Zhang, DP Sangurdekar, ... Journal of Alzheimer's Disease 46 (4), 947-961, 2015 | 51 | 2015 |
| Genome-wide transcriptional and physiological responses of Bradyrhizobium japonicum to paraquat-mediated oxidative stress AJ Donati, JM Jeon, D Sangurdekar, JS So, WS Chang Applied and environmental microbiology 77 (11), 3633-3643, 2011 | 48 | 2011 |
| Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients B Rhead, IS Brorson, T Berge, C Adams, H Quach, SM Moen, ... PLoS One 13 (10), e0206511, 2018 | 44 | 2018 |
| Rapid strain improvement through optimized evolution in the cytostat A Gilbert, DP Sangurdekar, F Srienc Biotechnology and bioengineering 103 (3), 500-512, 2009 | 39 | 2009 |
| Reconstruction of Escherichia coli transcriptional regulatory networks via regulon-based associations H Zare, D Sangurdekar, P Srivastava, M Kaveh, A Khodursky BMC systems biology 3, 1-12, 2009 | 33 | 2009 |
| Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring PA Calabresi, DL Arnold, D Sangurdekar, CM Singh, A Altincatal, ... Multiple Sclerosis Journal 27 (10), 1497-1505, 2021 | 29 | 2021 |
| Association of serum neurofilament light levels with long-term brain atrophy in patients with a first multiple sclerosis episode T Plavina, CM Singh, D Sangurdekar, C de Moor, B Engle, A Gafson, ... JAMA network open 3 (11), e2016278-e2016278, 2020 | 23 | 2020 |
| Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells E Bame, H Tang, JC Burns, M Arefayene, K Michelsen, B Ma, I Marx, ... Clinical & Translational Immunology 10 (6), e1295, 2021 | 20 | 2021 |
| Natalizumab reduces serum concentrations of neurofilament light chain in secondary progressive multiple sclerosis patients from the phase 3 ASCEND study (S12. 008) R Kapoor, F Sellebjerg, HP Hartung, D Arnold, MS Freedman, D Jeffery, ... Neurology 92 (15_supplement), S12. 008, 2019 | 17 | 2019 |
| Effects of prior alkylating therapies on preinfusion patient characteristics and starting material for CAR T cell product manufacturing in late-line multiple myeloma J Rytlewski, D Madduri, J Fuller, TB Campbell, A Mashadi-Hossein, ... Blood 136, 7-8, 2020 | 11 | 2020 |
| Molecular and phenotypic profiling of drug product and post-infusion samples from CRB-402, an ongoing: phase I clinical study of bb21217 a BCMA-directed CAR T cell therapy OC Finney, A Yeri, P Mao, C Pandya, E Alonzo, G Hopkins, S Hymson, ... Blood 136, 3-4, 2020 | 11 | 2020 |
| Natalizumab reduced serum levels of neurofilament light chain in secondary progressive multiple sclerosis patients from the phase 3 ASCEND study R Kapoor, F Sellebjerg, HP Hartung, DL Arnold, MS Freedman, D Jeffery, ... MULTIPLE SCLEROSIS JOURNAL 24, 988-988, 2018 | 11 | 2018 |
| Serum neurofilament light (NfL) for disease prognosis and treatment monitoring in multiple sclerosis patients: is it ready for implementation into clinical care?. P Calabresi, J Kuhle, DL Arnold, CM Singh, RP Kinkel, L Kappos, ... Multiple Sclerosis Journal 24, 59-60, 2018 | 11 | 2018 |
Arkady KhodurskyПотвърден имейл адрес: umn.edu
